Law360, New York (January 09, 2009) -- A shareholder of medical technology company Medtronic Inc. has filed a derivative suit alleging that the company’s directors and executives inflated the company’s earnings through a physician kickback scheme and other unlawful promotion of the off-label use of its Infuse Bone Graft product, which has been linked to serious health complications.
Richard M. Gulbrandsen filed the shareholder derivative complaint in Minnesota’s Fourth Judicial District Court, in Hennepin County, seeking compensatory and putative damages, among other penalties, and asking that the company’s...
